We evaluated 10 patients with histologically typical polyfor controls (P ϭ 0.005 
Introduction
The inflammatory myopathies are defined by a set of an immune-mediated inflammatory myopathy is usually categorized as polymyositis. characteristics including muscle weakness, elevated levels of creatine kinase (CK) in serum, myopathic potentials Several studies have suggested that mitochondrial changes are more common in IBM than in polymyositis. Mitochondrial with irritability on electrodiagnostic testing, and myopathic changes with inflammation on pathological examination of DNA (mtDNA) deletions have been found in at least half of patient populations with IBM (Oldfors et al., 1993 (Oldfors et al., , 1995 . muscle (Plotz et al., 1989; Dalakas, 1994) . Muscle pathology also provides a basis for subdividing the The mitochondrial abnormalities in IBM are manifest by an excess of muscle fibres with deficient cytochrome oxidase inflammatory myopathies (Carpenter and Karpati, 1992) . Perifascicular atrophy strongly supports a diagnosis of (COX) activity and ragged red fibres with excessive staining for succinate dehydrogenase (SDH) (Oldfors et al., 1993) . dermatomyositis. Vacuoles, rimmed by granular basophilic material, in muscle fibres suggest inclusion body myositis Mitochondrial abnormalities have been described in polymyositis without inclusion bodies (Watkins and Cullen, (IBM) . In the absence of these two pathological findings, 1987; Campos et al., 1995) , but are generally thought to be 1992). The 10 patients with polymyositis and COX-negative muscle fibres shared clinical and laboratory features that are unusual (Rifai et al., 1995) .
The routine evaluation of muscle biopsies at Washington usually part of inflammatory myopathy syndromes, including proximal weakness, myopathic electromyograms with University, St Louis, includes staining for COX activity. Over a 5-year period, we noted that an unexpectedly high 'irritative' features such as fibrillations and positive sharp waves, and elevated levels of serum CK. Nine of these 10 number of biopsies (10, i.e. 21%) from patients with diagnoses of polymyositis frequently showed muscle fibres with patients were examined at the Neuromuscular Clinic at Washington University School of Medicine, St Louis. deficient COX activity (Ͼ3% of the total number). These biopsies did not show vacuoles on serial haematoxylin and Detailed clinical and electrodiagnostic records were available on all 10 COX-negative polymyositis patients as well as on eosin (H&E) stained sections, nor did they show congophilic material, with or without vacuoles, on Congo-red stained six of the 12 polymyositis patients without COX-deficient fibres. Controls included dermatomyositis (10 patients), an sections under a polarized filter. We report the clinical features and mtDNA abnormalities in these 10 patients.
age-matched group of 13 patients with no primary muscle disease (nine with denervation on muscle biopsy and four normals), and two patients with vacuolar myopathies. Strength was measured bilaterally in nine muscle groups
Method
(arm abduction, elbow flexion, elbow extension, wrist
Muscle biopsies
extension, hip flexion, knee extension, knee flexion, ankle All muscle specimens were removed by an open biopsy dorsiflexion and hand grip) using a hand-held dynamometer, procedure and evaluated by a neuromuscular specialist (A.P.)
as previously described (Pestronk et al., 1994) . Results, in at Washington University, St Louis. Biopsy features necessary pounds, for each muscle were divided by the expected to support a diagnosis of polymyositis included inflammatory strength for an adult of the same sex in that muscle (from cell infiltrates, especially in endomysial regions, and standards established in the Washington University myopathic changes, including variation in muscle fibre size, neuromuscular clinic) and multiplied by 100 to obtain a and some evidence of disease activity, such as necrosis percentage of normal. An overall percentage of normal was with phagocytosis and regenerating muscle fibres. Increased determined by deriving an average of the data from individual amounts of endomysial connective tissue were present in muscles. A change in strength of ജ12 units is significant. biopsies from patients with longer histories of weakness. For this study, the presence of even one muscle fibre containing a rimmed vacuole in the biopsy excluded patients Mitochondrial DNA methods from categorization as typical polymyositis. The possibility Total DNA was extracted from skeletal muscle by standard of sampling error was minimized by the large size of the proteinase K and SDS (sodium dodecyl sulphate) methods. biopsies, usually containing at least 1000 muscle fibres, and
The presence of mtDNA deletions was analysed by the by the examination of multiple sections from each muscle.
widely interspaced primer polymerase chain reaction (PCR) Polymyositis biopsies were subdivided into groups with technique (Johns and Hurko, 1989; Johns et al., 1989) . normal or excess numbers (Ͼ3%) of muscle fibres with Briefly, the entire mitochondrial genome is screened for deficient COX activity (12 and 10 patients, respectively).
deletions using a set of oligonucleotide primer pairs that are Muscle biopsies were quickly frozen in isopentane cooled spaced too widely apart for amplification of normal mtDNA. with liquid nitrogen. Cryostat-cut cross sections of muscle However, in the presence of a deletion that does not include were stained with the following: H&E; Gomori's modified either primer, significant amplification of deleted mtDNA trichrome; NADH-tetrazolium reductase; ATPase after will occur. Using standard PCR conditions, the resultant incubation at pH 9.4, 4.6 or 4.3; Verhoff-van Giesen;
widely interspaced PCR products are visualized in agarose periodicacid-Schiff; COX; SDH; acid phosphatase; alkaline gels. phosphatase; non-specific esterase; Congo red; Sudan black; amylophosphorylase (modified Takeuchi method). To determine the percentage of muscle fibres that were COX-negative,
Illustrative case history
a randomly selected region of 300 muscle fibres cut in cross-A 53-year-old female (Patient 3) presented for re-evaluation section was evaluated at ϫ40 magnification. The number of of polymyositis. An elevated serum CK of 709 was discovered fibres with negative COX staining was divided by the total during an evaluation for anaemia 15 years previously. At number of muscle fibres. that time, she had no complaints related to disorders of muscle. Six years prior to presentation, she began to notice difficulty with climbing stairs. A diagnosis of polymyositis was based upon a myopathic EMG and right thigh muscle
Patients
The diagnosis of polymyositis, with or without COX-deficient biopsy with myopathic changes and cellular infiltrates. Prednisone treatment for several years produced no benefit. muscle fibres, was made by standard criteria prior to, and independently of, mtDNA analysis (Carpenter and Karpati, Her weakness progressed, necessitating a cane for ambulation In the 10 patients with polymyositis and COX abnormalities, with a resting blood pressure of 160/100. General medical 4.2-27.4% of the total muscle fibres were COX-negative examination was unremarkable. Cranial nerve examination (Fig. 1) . In each of the normal subjects and control patients showed mild bilateral orbicularis oculi weakness, but was (with diseases other than vacuolar myopathies), including the otherwise unremarkable. Diffuse limb weakness was greater other 12 with polymyositis, COX-negative muscle fibres proximally (Medical Research Grade, 3ϩ/5) than distally accounted for Ͻ0.5% of the total. In one patient (Patient 7) (4/5). Deep tendon reflexes were absent at the ankles, but a muscle biopsy that had been performed 10 years previously otherwise unremarkable. Pain and vibratory sensation were showed more inflammation, but many fewer COX-negative mildly reduced distally in the feet. Co-ordination was intact. muscle fibres, than the later biopsy. Fibres with excessive Gait was waddling and unsteady. A repeat EMG showed SDH staining, consistent with mitochondrial proliferation, myopathic units with irritability. The muscle biopsy showed were found in most of the biopsies from patients in the endomysial inflammatory infiltrates, variation in muscle fibre COX-negative polymyositis group. Most muscle fibres with size, and a mild increase in endomysial connective tissue.
excessive SDH staining were COX-negative. However, many COX activity was absent in an excessive number of muscle COX-negative muscle fibres, 50-80%, had no clear excess of fibres (5.6%) scattered throughout the biopsy. Addition of SDH staining. H&E stains in all 22 patients with polymyositis azathioprine at a dose of 250 mg/day produced no notable showed typical endomysial cellular infiltrates and myopathic changes (Fig. 2) . Inflammatory infiltrates present in biopsies change in strength. 6 to 120 months. The control polymyositis patients without COX-negative fibres had disease durations ranging from 3 to 72 months, not significantly different from the COXfrom patients with COX-negative polymyositis were indistinguishable histochemically from other polymyositis negative polymyositis patients. Serum CK measurements were only moderately elevated patients. COX-negative muscle fibres were usually not associated with inflammatory infiltrates or necrotic changes.
in the COX-negative polymyositis group, averaging 363Ϯ115 U/l, with the highest value being 1200 U/l. In polymyositis patients with normal COX staining of muscle fibres, Ͼ71% of patients had serum CK values Ͼ1200 U/l (P ϭ 0.003).
Mitochondrial DNA testing
Of the 10 polymyositis biopsies with an excess of COX-A final characteristic of the COX-negative polymyositis patients was a poor response to prednisone treatment. None negative muscle fibres, multiple mtDNA deletions were found in nine (90%) ( Table 1 ). The biopsy without mtDNA of the eight patients who were treated with prednisone had significant improvement on quantitative muscle testing, or deletions, from Patient 8, had a similar morphological appearance to those with deletions. The biopsy performed any history of functionally useful benefit. At the time of their last evaluation most patients had either discontinued 10 years earlier on Patient 7, which had few COX-negative muscle fibres, did not have multiple mtDNA deletions. The prednisone entirely, or been tapered to low dosages as new immunosuppressive medications were added. This is in frequencies of multiple mtDNA deletions in the control groups (Table 1) were 8% for COX-positive polymyositis, contrast to the polymyositis-control patients of whom five out of six had been treated with corticosteroids, and four of 20% for dermatomyositis and 23% for age-matched controls with no primary muscle pathology. The two patients with those five showed significant improvement in strength. The patient without improvement had the longest disease course vacuolar myopathies, presumably IBM, had multiple mtDNA deletions.
(6 years). No improvement could be documented after treatment of COX-negative polymyositis patients with other The multiple mtDNA deletions in the polymyositis patients ranged from 2 to 10 kb in length. They were predominantly immunosuppressive medications, including azathioprine (three patients), methotrexate (two patients), cyclosporine clustered near an upstream breakpoint at nucleotide position 16 058-16 070 in the non-coding displacement-loop. The (two patients) and intravenous immunoglobulin (one patient). majority of the deletions were bounded by small, imperfect direct repeats, but some deletion junctions contained larger, perfect direct repeats or had no direct repeat. In four patients
Discussion
We studied 10 patients with inflammatory myopathies who mtDNA was also assayed by Southern blot methodology which confirmed the presence of deletions (S. Dimauro, had a large excess of muscle fibres with negative staining for COX. The percentage of the COX-negative muscle fibres unpublished observations).
was ജ4% in each of the 10 biopsies. This figure is far above the range for normal for age-matched controls (Ͻ 0.5%) from previously published data and from our laboratory Clinical correlations (Table 2) The 10 patients with polymyositis and COX-negative muscle (Muller-Hocker, 1990; Rifai et al., 1995) . The range of frequencies of COX-negative muscle fibres in these 10 fibres had an average age at onset of disease of 61Ϯ3 years. This is significantly older (P ϭ 0.02) than the average age patients (4.2-27.4%) is also considerably higher than those reported in a series of patients with late-onset mitochondrial of the other 38 adults who had a muscle biopsy and polymyositis diagnosed at our centre during the same time myopathy (Johnston et al., 1995) . Only one of their nine patients had Ͼ3% of muscle fibres with COX-negative period (52Ϯ3 years). Overall, progression of weakness was slow in the COX-negative polymyositis group. Serial staining. Ragged red fibres and COX-negative muscle fibres have been described previously in inflammatory myopathies, quantitative strength measurements were made in three patients. They declined by an average of 4% of predicted but have not been quantified or correlated with clinical CK ϭ serum creatine kinase in U/l. Weakness distribution: P ϭ proximal, D ϭ distal, S ϭ symmetric, F ϭ facial. % COX-negative fibres ϭ percentage of 300 randomly selected fibres with no staining for cytochrome oxidase.
outcome (Mikol and Engel, 1994; Rifai et al., 1995) . In one a corticosteroid-resistant myopathy, revealed more chronic series of polymyositis and dermatomyositis patients, ragged appearing myopathic changes with increased endomysial red fibres were quantified; seven out of eight of the older fibrosis. There was less inflammation but numerous COXpatients (age ജ39 years) had Ͻ1% ragged red fibres (defined negative muscle fibres were present. by excessive SDH staining) and 'a small proportion' of COXMutations producing multiple mtDNA deletions are known negative fibres which were not ragged red fibres (Rifai et al., to develop in skeletal muscle with normal ageing (Harding, 1995) . One patient had 4.85% ragged red fibres; none of 1992; Simonetti et al., 1992; Lee et al., 1994) . the younger patients (age Ͻ39 years) had Ͼ0.2% ragged In IBM muscle, multiple mtDNA deletions are thought to red fibres.
arise clonally and to be propagated in individual muscle The presence of an excess of COX-negative muscle fibres fibres (Oldfors et al., 1995) . Postulates regarding stimuli for in our myositis patients correlated with the presence of the development of deletions have included free-radical mtDNA deletions in muscle. The mtDNA deletions occurred generation, and abnormal accuracy, or rates, of mtDNA in 90% of patients with polymyositis and COX-negative replication (Corral-Debrinski et al., 1992; Soong et al., 1992) . muscle fibres. The two older patients with vacuolar
The mitochondrial abnormalities in our myositis patients myopathies, with or without inflammation, formed another could either be a primary event that then stimulates myopathy small group that had mtDNA deletions (two out of two; and inflammatory infiltration, or be secondary to, and 100%). These two patients also had a high frequency of stimulated by, the inflammation, or muscle fibre degeneration COX-negative muscle fibres. It has been reported that mtDNA and regeneration. Mitochondria with DNA deletions are felt deletions occur frequently in patients with IBM, a disorder to have an advantage during replication leading to increased that has vacuolar changes in muscle fibres identical to those numbers relative to mitochondria with wild-type DNA in these two patients (Oldfors et al., 1993 (Oldfors et al., , 1995 . The other (Yoneda et al., 1992) . patient groups, none of which had an excess of COX-negative Whatever the mechanisms of development of the muscle fibres, had a much lower prevalence of mtDNA mitochondrial abnormalities, our 10 patients with deletions (P ϭ 0.005), with 8% in polymyositis and normal inflammatory myopathies and COX-negative muscle fibres COX staining, and 23% in age-matched controls without had clinical features suggestive of IBM rather than primary muscle disease.
polymyositis (Yunis and Samaha, 1971; Danon et al., 1982) . Multiple mtDNA deletions in a tissue are generally found in Their clinical characteristics included presentation later in autosomally transmitted and sporadic mitochondrial diseases life (average age, 61 years) than other patients with (Zeviani et al., 1989; Cormier et al., 1991; Ohno et al., 1991;  polymyositis, slow progression of weakness, selective Suomalainen et al., 1992; Hirano et al., 1994) . The multiple weakness of knee extension that became more apparent as mtDNA deletions in our polymyositis patients with COXthe disease evolved, and little or no improvement during negative fibres were probably an acquired trait. The sequential immunosuppressive treatment. A few patients had weakness biopsies in Patient 6, with the second but not the first showing of the tibialis anterior muscle. However, our patients generally mtDNA deletions, support this idea. The initial biopsy did not have much early involvement of ankle dorsiflexion showed myopathic changes and endomysial inflammation, a or wrist flexion, two muscle groups often identified as weak combination of changes that was interpreted as being typical in IBM. On laboratory testing, most of the COX-negative of polymyositis. COX-negative muscle fibres were sparse, patients had only mildly elevated serum CK. The average similar to the frequency seen in our control groups. The biopsy conducted 11 years later, as part of a work-up for CK in this group was 363 U/l serum, Ͻ10% of the average
